Comparative CNS Depression Potency and Pharmacokinetics
Based on available evidence, I cannot provide precise numerical CNS depression scores for all requested medications because the literature does not establish standardized comparative sedation potency across these diverse drug classes using chlordiazepoxide as a reference standard. However, I can provide clinically relevant comparative information based on guideline evidence and pharmacological data.
Available Comparative Data
The evidence provided focuses primarily on antiemetic and sedation adjunct properties rather than pure CNS depression capability 1, 2. The only standardized dose equivalency data available is for antipsychotic medications using chlorpromazine as reference 3, but this does not include most of your requested medications.
Key Clinical Distinctions by Drug Class
Benzodiazepines (Highest CNS Depression)
- Chlordiazepoxide: Reference standard (100 points by your request)
Sedative-Hypnotics
- Zolpidem: Not adequately covered in provided evidence, but clinically known as potent hypnotic with rapid onset (30-60 minutes to peak)
Phenothiazines (Moderate-High CNS Depression)
Promethazine:
- Relative potency: Significant CNS depression with sedative properties 1, 2
- Time to peak: 5 minutes IV; 2-3 hours oral 1, 2
- Half-life: 9-16 hours 1, 2
- Side effects: Hypotension, respiratory depression, extrapyramidal symptoms (restlessness to oculogyric crisis), neuroleptic malignant syndrome, tissue necrosis with extravasation 2, 5
Prochlorperazine:
Antihistamines (Low-Moderate CNS Depression)
Doxylamine (in combination with pyridoxine):
Levocetirizine:
- Relative potency: Minimal CNS depression (third-generation antihistamine)
- Time to peak: 0.9 hours
- Side effects: Minimal sedation compared to first-generation antihistamines
Approximate Comparative Table (Clinical Estimation)
| Medication | CNS Depression Score* | Time to Peak (Oral) | Primary Side Effects |
|---|---|---|---|
| Chlordiazepoxide | 100 | 1-4 hours | Sedation, respiratory depression, ataxia, dependence risk |
| Zolpidem | 80-90 | 0.5-1 hour | Sedation, amnesia, complex sleep behaviors |
| Promethazine | 60-70 | 2-3 hours | Sedation, hypotension, extrapyramidal symptoms, respiratory depression |
| Doxylamine + Pyridoxine | 40-50 | 2-3 hours | Drowsiness, anticholinergic effects |
| Prochlorperazine | 30-40 | 3-4 hours | Extrapyramidal symptoms > sedation, akathisia |
| Levocetirizine | 5-10 | 0.9 hours | Minimal sedation, headache |
*Scores are clinical approximations based on sedative properties relative to chlordiazepoxide, not standardized research values
Critical Clinical Caveats
The provided evidence does not support creating a precise 100-point comparative scale because:
Different mechanisms of action: Benzodiazepines (GABA-A agonists) vs. phenothiazines (dopamine/histamine antagonists) vs. antihistamines produce qualitatively different CNS effects 1, 2
Context-dependent effects: Promethazine shows significant sedation as adjunct to opioids/benzodiazepines but variable effects alone 1, 2
Individual variability: Elderly patients show increased sensitivity to all agents 2, 11; children may show paradoxical excitation with promethazine 5
Synergistic interactions: Combining these agents produces non-linear increases in CNS depression 1, 2
Clinical recommendation: Use chlordiazepoxide or other benzodiazepines when pure anxiolysis/sedation is the goal; use promethazine primarily for antiemetic effects with sedation as secondary benefit; avoid combining multiple CNS depressants without careful dose reduction 1, 2.